TD Cowen Upgrades Moderna to Outperform, Raises Price Target to $180
TD Cowen analyst Tyler Van Buren upgrades Moderna (NASDAQ:MRNA) from Market Perform to Outperform and raises the price target from $150 to $180.
Citigroup Upgrades Charles Schwab to Buy, Lowers Price Target to $75
Citigroup analyst Chris Allen upgrades Charles Schwab (NYSE:SCHW) from Neutral to Buy and lowers the price target from $83 to $75.
Wells Fargo Upgrades Eli Lilly to Overweight, Raises Price Target to $375
Wells Fargo analyst Mohit Bansal upgrades Eli Lilly (NYSE:LLY) from Equal-Weight to Overweight and raises the price target from $360 to $375.
Wells Fargo Upgrades JPMorgan Chase to Overweight, Raises Price Target to $155
Wells Fargo analyst Mike Mayo upgrades JPMorgan Chase (NYSE:JPM) from Equal-Weight to Overweight and raises the price target from $148 to $155.
Keefe, Bruyette & Woods Upgrades Truist Finl to Market Perform, Lowers Price Target to $45
Keefe, Bruyette & Woods analyst David Konrad upgrades Truist Finl (NYSE:TFC) from Underperform to Market Perform and lowers the price target from $47 to $45.
Telsey Advisory Group Reiterates Market Perform on G-III Apparel Group, Maintains $14 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates G-III Apparel Group (NASDAQ:GIII) with a Market Perform and maintains $14 price target.
Telsey Advisory Group Reiterates Outperform on BRC, Maintains $12 Price Target
Telsey Advisory Group analyst Sarang Vora reiterates BRC (NYSE:BRCC) with a Outperform and maintains $12 price target.
Telsey Advisory Group Reiterates Outperform on Honest Co, Maintains $6 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Honest Co (NASDAQ:HNST) with a Outperform and maintains $6 price target.
Needham Reiterates Buy on Genius Sports, Maintains $7 Price Target
Needham analyst Bernie McTernan reiterates Genius Sports (NYSE:GENI) with a Buy and maintains $7 price target.
Raymond James Maintains Outperform on ACRES Commercial Realty, Raises Price Target to $13.5
Raymond James analyst Stephen Laws maintains ACRES Commercial Realty (NYSE:ACR) with a Outperform and raises the price target from $13 to $13.5.